Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Murine interleukin- 12
Most Correlated Studies
- Drug target sets for approved compounds
- CD4+ T cells stimulated and then restimulated in the presence or absence of natalizumab
- Influence of anti-CD25 mAb on the transcriptome of activated PBMC
- Cord blood mononuclear cells depleted of PIM kinases under Th1 or Th2 polarizing conditions
- Response to IL-12 and Type I IFN with or without TCR and CD28 T-lymphocyte stimulation
Most Relevant Literature
- Deciphering site 3 interactions of interleukin 12 and interleukin 23 with their cognate murine and h…
- Murine cytotoxic CD4+ T cells in the tumor microenvironment are at a hyper-maturation stage of Th1 C…
- Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice.
- Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melano…
- Multifaceted Nano-DEV-IL for Sustained Release of IL-12 to Avert the Immunosuppressive Tumor Microen…
Most Relevant Clinical Trials
- Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Huma…
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the …
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the …
- Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-G…
